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Mediators of Ca2 -Dependent Secretion
by Archana Chaudhry* and Ronald P. Rubin*
Ca", an obligatory mediator of the secretory process, acts in concert with other second messen-
gers that further amplify or inhibit the secretory response. In this overview, we will consider the
relative roles of diacylglycerol (DAG), arachidonic acid, and cyclic AMP (cAMP) in modulating
Ca2,-dependent secretion in nonexcitable cells. DAG, a product of phospholipase C (PLC)-cata-
lyzed breakdown of phosphoinositides, stimulates protein kinase C. Ca2" ionophores and phorbol
esters (or DAG analogues) elicit a synergistic secretory response in the exocrine pancreas and
parotid gland. These findings suggest that the complete activation of secretion requires stimula-
tion of both Ca2+-dependent and protein kinase C-dependent pathways. Hydrolysis of
phospholipids can also lead to the liberation of arachidonic acid in secretory cells. Endogenously
generated arachidonic acid inhibits polyphosphoinositide synthesis in exocrine pancreas, leading
to inhibition of agonist-induced IP3 formation, Ca2+-mobilization and amylase secretion. By con-
trast, arachidonic acid and its metabolites stimulate PLC in the rabbit peritoneal neutrophil,
causing Ca2+-mobilization and lysosomal enzyme secretion. Arachidonic acid can thus serve as a
positive or negative feedback regulator of secretion induced by Ca21-mobilizing agonists. Finally,
in the parotid gland, stimulation ofamylase secretion by norepinephrine, the physiological media-
tor, which stimulates both the a and P adrenoceptors, requires the interaction of both Ca + and
cAMP pathways to produce a full secretory response. These studies, taken together, indicate that
phosphoinositide and cAMP-dependent pathways play coordinate roles in signal transduction,
leading to the Ca2+-mediated secretion.
The role of calcium (Ca2") in stimulus-secretion
coupling has been unequivocally established. In electri-
cally excitable cells such as the neuron, adrenal medul-
lary chromaffin cell, the P cell of the endocrine
pancreas, and cells of the adeno- and neurohypophysis,
the rise in cellular Ca2" following stimulation is
derived to a large extent from influx of cation through
voltage-sensitive channels (1). In nonexcitable secre-
tory cells, such as those of exocrine glands and neutro-
phils, cellular stores of Ca2' play a more predominant
role in regulating secretion, although Ca2" influx
through receptor-operated channels also increases cel-
lular Ca2' availability (Fig. 1). The initial secretory
response seems dependent on Ca2' released from intra-
cellular stores, but prolonged secretion requires the
presence of extracellular Ca2' (2).
The concept that increases in intracellular ionic
Ca2"stimulate secretion in nonexcitable cells is sup-
ported by the following pieces of evidence: a) secreta-
gogues evoke increases in cytosolic Ca2" (3,4) and
cause a rapid efflux of 45Ca from cells (2); b) Ca2"
ionophores which bypass receptors to raise cytoplas-
mic Ca2' stimulate enzyme secretion (4); c) depletion
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of cellular Ca2" inhibits secretion (2); and d) amylase
secretion is stimulated when increasing concentra-
tions of buffered Ca2" are introduced into the cytosol
of electropermeabilized cells (5).
Ca2"-mobilizing agonists stimulate phospholipase C
(PLC), which catalyzes the phosphodiesteratic cleav-
age of phosphatidylinositol 4,5-bisphosphate (PIP2)
(Fig. 1). This leads to the formation of 1,4,5-inositol
trisphosphate (1P3) and diacylglycerol (DAG), both of
which have important second messenger roles. 1,4,5-
IP3 releases cellular Ca2' by interacting with a spe-
cific receptor site on the endoplasmic reticulum (6),
and DAG activates protein kinase C, a key regulatory
enzyme (7). Arachidonic acid is also liberated from
phosphoinositides during stimulation by secreta-
gogues, and free arachidonic acid and/or its metabo-
lites may also serve as cellular messengers to
modulate the secretory response (8). Also, some secre-
tory cells possess a signaling system that uses cyclic
AMP (cAMP) as a second messenger. In such systems
Ca2' and cAMP may act either sequentially or in con-
cert to regulate secretion. Simultaneous changes in
the intracellular concentrations of cytosolic Ca2' and
cAMP have been reported after stimulation of secre-
tory cells by a variety of secretagogues (9,10). How-
ever, in contrast to Ca2 , cAMP has not been
characterized as a direct mediator of exocytosis.
In this brief overview, we will consider the concept
that the second messengers DAG, arachidonic acid,CHAUDHRYAND RUBIN
Ca2+ Agc.
FIGURE 1. A hypothetical model depicting the various second mes-
sengers that can regulate cellular secretion. Occupation of
receptors (R) by calcium-mobilizing agonists (Agca) activates
phospholipase C (PLC) through a G protein (Gp). PLC-mediated
breakdown of phosphatidylinositol 4,5-bisphosphate (PIP2)
leads to the formation of inositol trisphosphate (1P3) and dia-
cylglycerol (DAG), both of which act as second messen-
gers-IP3 by mobilizing intracellular Ca2" and DAG by
activating protein kinase C. Ca2' and protein kinase C act syn-
ergistically to promote a full secretory response. The increase
in intracellular Ca2" levels brought about by 1,4,5-IP3, or via
influx through receptor-operated calcium channels, can stimu-
late phospholipase A2, and lead to arachidonic acid release
(AA). Arachidonic acid and its metabolites can either amplify
or inhibit agonist-induced rises in cytosolic Ca21 thus modulat-
ing secretion. Agonists that cause secretion by modulating cyc-
lic AMP (Ag,AMp) express their actions via stimulatory and
inhibitory G proteins (G. and G;) to activate and inhibit adeny-
late cyclase, respectively. Cyclic AMP can act in concert with
Ca2+ to promote secretion, perhaps by enhancing Ca21
availability.
and cAMP interact with Ca2" to modulate the secre-
tory response (Fig. 1). We will employ the parotid and
pancreatic acinar cells, as well as the rabbit neutro-
phil, to offer evidence to support this thesis.
A large body of evidence suggests that in many
tissues optimal secretion requires both Ca2' and DAG
(Fig. 1). Nishizuka and his colleagues (7) first demon-
strated that DAG activates a phospholipid-dependent
kinase (protein kinase C) by increasing the affinity of
the kinase for Ca2". Thus, in the presence of DAG,
protein kinase C can be maximally stimulated at sub-
micromolar concentrations of Ca2+. The interactions
between Ca2+ and protein kinase C in cellular secre-
tion have been probed by using calcium ionophores
(which bypass receptors to raise cytoplasmic Ca2')
and phorbol esters (which substitute for DAG) to
activate the Ca2+-dependent and protein kinase C-
dependent pathways separately. In isolated pancre-
atic acini, phorbol 12,13-dibutyrate (PDBu) when
added together with a threshold concentration of the
Ca2+ ionophore, ionomycin, causes a synergistic
potentation of amylase secretion, with no further ele-
vation in cytoplasmic Ca2+ than the one elicited by
ionomycin alone (Fig. 2). Diacylglycerols containing
unsaturated fatty acids also stimulate amylase secre-
tion and exhibit synergistic effects on secretion in
combination with ionomycin (4). These results sug-
gest that complete activation of amylase secretion by
the pancreas requires stimulation of both Ca2+-depen-
dent and protein kinase C-dependent pathways. Simi-
lar synergistic effects of ionophores and phorbol
esters have been reported in other model secretory
systems (11,12).
Apart from interacting with the protein kinase C
pathway, Ca2" may interact with the arachidonic acid
messenger system to modulate secretion (13). Mam-
malian phospholipids are enriched in arachidonic
acid, and Ca2"-mobilizing agonists liberate free
arachidonic acid either through activation of
phospholipase A2, the sequential activation of PLC
and DAG lipase, or phosphatidate-specific
phospholipase A2 (13). For example, the mucarinic
agonist carbachol elevates free arachidonate levels in
pancreatic acinar cells (14). The time course of this
event parallels that of other cellular responses to
carbachol, including IP3 accumulation and amylase
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FIGURE 2. Potentiation by phorbol dibutyrate of ionomycin-induced
amylase secretion without a further rise in [Ca21]. Rat pancre-
atic acini were incubated in the presence of either phorbal
dibutyrate (PDBu) (1 FM), or ionomycin (0.3 gM), or PDBu plus
ionomycin (P+I). [Ca2+]i (Quin-2 fluorescence) and amylase
secretion were determined after 10 and 30 min, respectively.
Double asterisks (**) indicate significantly different from con-
trol value (p < 0.05). Modified from Merritt and Rubin (4).
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phospholipids elicited by carbachol (14). These find-
ings indicate that in exocrine pancreas, arachidonic
acid inhibits the synthesis of the polypholphoinosi-
tide pool used by Ca2'-mobilizing agonists.
To confirm the inhibitory role of endogenously
released arachidonic acid on phosphoinositide turno-
ver and, consequently, on agonist-mediated Ca2"
mobilization as well as amylase secretion, we utilized
tetrahydrocannabinol (THC) to increase endogenous
T* levels of unesterified arachidonate. THC is an inhibi-
tor of acyl-CoA transferase and stimulates
arachidonic acid release from cells by activating
25 50 phospholipase A2 (17-19). In acinar cells prelabeled
Id (PM) with both [3H]arachidonic acid and [32P]pi, THC causes a significant increase in levels of free
3H]IP3 formation by [3H]arachidonic acid that correlates with a corre-
cells. Cells prelabeled sponding decrease in the steady-state levels of PIP2
d for 5 min with vari- (Fig. 4). The effects of THC on arachidonate release
l-inedxued ocacrubmulal and [3P]Pi levels are dose-related over the concentra-
g the radioactivity in tion range of 1 to 20 jM (unpublished observations).
mean ± SE (n = 5). Pretreatment with THC causes a dose-related inhibi-
ferent from samples tion of [3H]IP3 accumulation (unpublished observa-
tions), as well as cytoplasmic Ca2' and amylase
secretion (Table 1) elicited by cerulein in the exocrine
nous arachidonic pancreas. These results indicate that endogenously
lent reduction in generated arachidonic acid and/or its metabolites can
14). The decrease serve as a negative feedback regulator of phosphoi-
,-stimulated PIP2 nositide turnover and, thus, inhibit agonist-induced
one does not pro- rises in cytosolic [Ca2'] and amylase secretion.
;, pretreatment of By contrast, in the rabbit neutrophil, the lipooxy-
arachidonic acid genase metabolite leukotriene B4 (LTB4) stimulates
on in response to IP3 accumulation, Ca21 mobilization, and enzyme
acid blocks the degranulation (20,21). Thus, in the neutrophil,
yo-inositol into arachidonate metabolites may amplify the agonist-
150 F
100 h
50~
0
0 5 30
100
80
6
C
60 8
I
201
N
40 L
CM
20
O
Time ( min )
FIGURE 4. Effect of THC on [3H]arachidonic acid (AA) and ['P]PIP2 levels in pancreatic acinar cells. Cells were simultaneously incubated
with[3H]AA (10 jiCi/mL),[32p]pi (10-25IiCi/mL), and carbachol (10 FM) for 15 min, atwhich time atropine (100gM) was added. After 75
min, the cells were resuspended in medium containing [3P]Pi (10-25 gCi/mL), and exposed to THC (20giM) for various times. Analysis
of[3H]AA acid and[M]PIP2 was carried out as previously described (14,18). Values are expressed as percent ofthe radioactivity in control
samples.
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Table 1. Inhibitory effects of THC on cerulein-stimulated
increases in cytosolic Ca2' and amylase secretion in rat
exocrine pancreas.'
[Ca2+]i Amylase release,
nM % total tissue content
Cerulein, 0.1 jM 294 ± 54 9.5 ± 0.5
Cerulein + THC, 5 jM 158 ± 30* 7.4 ± 0.1*
aFura-2 loaded acinar cells were exposed to cerulein in the pres-
ence and absence of THC and [Ca2+]i was calculated as previously
described (25). Amylase secretion was determined in acini incubat-
ed for 30 min with cerulein in the presence and absence of THC.
Basal values for [Ca2+]i and amylase secretion have been subtracted
from the data that is shown here as mean ± SE (n = 3-5).
*Significantly different from samples treated with cerulein alone
(p < 0.05).
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induced breakdown of polyphosphoinositides by being
exported from the cell and, subsequently, acting as
receptor agonists on neighboring cells to stimulate
PLC and mobilize cellular Ca2". A positive feedback
mechanism also appears operative in the blood plate-
let (22) and rat corpus luteum (23). Thus it appears
that agonist-induced liberation of arachidonic acid
can either amplify Ca2"-induced secretion or inhibit
it, depending upon the secretory system under
scrutiny.
Recent evidence suggests that Ca2+ can also interact
with the cAMP-dependent pathway to enhance the
secretory responses of secretagogues. Cyclic AMP
generated through beta adrenoceptor action appears
to be a critical modulator of amylase secretion by the
rat parotid gland. By contrast, Ca2+-mobilizing ago-
nists which express their actions through muscarinic
and a-adrenergic receptors cause a predominance of
water and electrolyte release (24). Norepinephrine
(NE), the physiological neurotransmitter for salivary
amylase secretion, which stimulates both f and a
adrenoceptors, requires participation of both the
cAMP and Ca2+ pathways to produce a full secretory
response. Figure 5 shows that amylase secretion
induced by NE is greater than the sum of the release
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FIGURE 6. Enhancement of isoproterenol-induced amylase release
by carbachol in parotid acinar cells. Cells were incubated for 15
min in the presence or absence of 1 FM carbachol (CCh) and 200
nM isoproterenol (ISO). Each value is mean ± SE (n = 3) with
basal release subtracted. Asterisk (*) indicates p < 0.05.
obtained when NE is used as an a adrenoceptor ago-
nist (in the presence of propranolol) and a P adre-
noceptor agonist (in the presence of prazosin).
Further support for an interaction between the
Ca2' and cAMP pathways comes from our observation
that a subthreshold concentration ofcarbachol causes
a significant enhancement of isoproterenol-induced
secretion (Fig. 6). The site of interaction between the
two transduction systems is distal to the catalytic site
of adenylate cyclase because carbachol failed to ele-
vate isoproterenol-stimulated cAMP levels (unpub-
lished observations). One possible explanation for the
above findings is that there is an enhancement ofCa2"
availability produced by the coordinate interactions
of the two pathways. Parotid acinar cells exposed to
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FIGURE 5. Effect of prazosin or propranolol on norepinephrine
(NE)-induced salivary amylase release. Rat parotid acinar cells
were exposed for 15 min to 500 nM NE in the presence and
absence of either 100 nM prazosin or 1 FM propranol. Values
are means ± SE with basal release subtracted (n = 3).
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FIGURE 7. Effect of carbachol (CCh) and isoproterenol (ISO), alone
and in combination, on the steady-state accumulation of 45Ca in
rat parotid acinar cells. Cells were incubated with 45Ca (8 gCi/
mL) for 60 min and then exposed to either CCh (100gM) or ISO
(200 nM) for various times. A third group of cells was pre-
treated for 2 min with 200 nM ISO prior to exposure to CCh.
The incubation was terminated by filtering the cells through
Millipore filters. The filters were counted, and the cellular 45Ca
content of each sample was calculated as a percent of its corre-
sponding control value. Each value is mean ± SE (n = 3-8).
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45Ca under steady-state conditions show an enhanced
45Ca accumulation in cells exposed to carbachol, but
not to isoproterenol (Fig. 7). However, the combina-
tion of carbachol plus isoproterenol produces a fur-
ther elevation in cellular 45Ca content. The above
findings, therefore, suggest that the Ca2'-mediated
pathway interacts with the cAMP-mediated pathway
to regulate amylase secretion by increasing Ca2'
availability.
In conclusion, this brief account has dealt with the
concept that phosphoinositide- and cAMP-dependent
pathways play coordinate roles in signal transduction
leading to the activation of Ca2'-mediated exocytotic
secretion. While Ca2+ appears to be a sine qua non for
activation of the secretory apparatus, there is con-
vincing evidence that DAG, arachidonic acid, and
cAMP serve to modulate this pivotal action ofCa2'. In
secretory cells it appears as though controls are
arranged in an integrative system in which informa-
tion from several levels or sources may influence the
final Ca2'-dependent message that is transmitted to
the secretory apparatus. Continued intensive experi-
mentation will be required to define the full scope of
the close association, if not tight coupling, between
Ca2+ and these messengers systems. The current
intensity of attention to this subject seems likely to
generate additional paradigms for this aspect of cell
activation.
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